Clinical Trials Directory

Trials / Completed

CompletedNCT06631898

To Check Dermatological Safety of Test Products by 24 Hours Patch Test on Adult Healthy Human Subjects.

Evaluation of Dermatological Safety of Test Products by 24 Hours Patch Test Under Complete Occlusion or Semi Occlusion or Open Patch on Adult Healthy Human Subjects.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
26 (actual)
Sponsor
NovoBliss Research Pvt Ltd · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

This is single-center, evaluator blinded study in healthy human subjects. single 24-hour application of sponsors provided test product along with positive and negative control will be kept in contact with the skin if subject under icclllusion or semi occlusion or open patch for at least 24 hours (± 2 hours). safety will be assed through the study by monitoring of adverse event A sufficient number 26 subject will be enrolled to get 24 completed the study. There are total three visits in this study and are optional visit pre-screening visit : Lactic Acid Stinging test\& Modified Dr baumenn's skin type questionnaire. Visit 01: Screening, Enrollment, and Patch Application (Day 01) Visit 02: Patch Removal After 24 hours of Application \& 30 ± 5 min irritation scoring upon patch removal Visit 03: 24 (± 2 hour) irritation scoring (Day 03) visit 04: subject will be contacted telephonically on Day 08 for any signs of irritation at patch application site. Follow-up visit for reactions if any to confirm recovery (optional deemed necessary) Irritation scoring at 168 ± 2 hours post-patch removal (Day 09)

Conditions

Interventions

TypeNameDescription
OTHERSaaTwae Bio-Natural Moisturizing CreamA 0.04 gm of test products along with controls (negative and positive) will be applied on the back of subjects i.e. between the scapula and waist through Finn chamber patch.

Timeline

Start date
2024-10-09
Primary completion
2024-10-11
Completion
2024-10-17
First posted
2024-10-08
Last updated
2025-02-28

Locations

1 site across 1 country: India

Source: ClinicalTrials.gov record NCT06631898. Inclusion in this directory is not an endorsement.